✦ LIBER ✦

A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain

✍ Scribed by A. E. Panerai; G. Monza; P. Movilia; M. Bianchi; B. M. Francucci; M. Tiengo

Book ID: 114783210
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 445 KB
Volume: 82
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1990.tb01584.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

✍ Michael C. Rowbotham; W. Rachel Duan; James Thomas; Wolfram Nothaft; Misha-Miros 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Evaluation of the efficacy and tolerabil

Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial

✍ E. Scaparro; G. Quadri; G. Virno; C. Orifici; M. Milani 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

A Randomized Withdrawal, Placebo-Control

A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

✍ Vinik, Aaron I.; Shapiro, Douglas Y.; Rauschkolb, Christine; Lange, Bernd; Karch 📂 Article 📅 2014 🏛 American Diabetes Association 🌐 English ⚖ 878 KB

Efficacy and tolerability of the novel t

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

✍ Pierre Tran; Phil Skolnick; Pal Czobor; N.Y. Huang; Mark Bradshaw; Anthony McKin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Clinical trial: the efficacy, impact on

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled study

✍ E. M. M. QUIGLEY; L. VANDEPLASSCHE; R. KERSTENS; J. AUSMA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

The efficacy of Combizym in the treatmen

The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study : SHANGHAI COMBIZYM CLINICAL COOPERATIVE GROUP

✍ Zhi Hua RAN; Yao Zong YUAN; Zhao Shen LI; Ji Yao WANG; Chun Hua ZONG; Wei Fen XI 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 165 KB